Intellectual Property
Learn why functional antibody claims now meet sufficiency standards at the Unified Patent Court (UPC), aligning with EPO practice and diverging from US enablement rules.
Read how a California court clarified General Public License obligations, narrowing reinstallation duties under GPLv2 and offering compliance guidance for open-source users.
Discover why trade secret claims from the Tenth Circuit clarify ownership, secrecy duties, and litigation risks when employees control disputed information.
Read why the court denied Lashify’s contempt motion, emphasizing the need for clear evidence and certified translations in patent enforcement disputes.
Rising IP claims tied to influencer content are reshaping compliance and social media, pushing companies to tighten controls and rethink creator oversight.
Discover what led a federal court to award attorneys’ fees under the Patent Act, but reject sanctions despite features “consistent with bad faith litigation.”
Read why the Federal Circuit limited a district court injunction in a patent dispute, allowing a drug company to conduct pre-approval research despite a competing patent.
Understand how bias toward task completion when using agentic AI can put your company’s intellectual property at risk and what you can do about it.
Learn why the Federal Circuit ruled that “clinically proven effective” dosage language could not confer patentability in a cardiovascular treatment patent.
Read about how AI technology licensing brings new IP risks. Agreements should address ownership, model training, liability, and regulatory compliance.
Daily Updates
Sign up for our free daily newsletter for the latest news and business legal developments.
